Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome

NCT02848274 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02848274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02848274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome
Lead sponsor
Stanford University
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2016
Completion date
March 31, 2027
Enrollment
2,000 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

mycosis fungoides, non-hodgkin's lymphoma